
|Articles|July 24, 2019
Versiti Acquires Cenetron Central Laboratories and Salus IRB
Advertisement
Versiti has announced the acquisition of Texas-based Cenetron Central Laboratories, and its subsidiary, Salus IRB. The acquisition will not impact Cenetron’s 40 employees, and the laboratory will maintain its name and current location in Austin.
For more details, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5




